Related Experiment Videos
Heat shock protects PC12 cells against MPP+ toxicity
Declan J Quigney1, Adrienne M Gorman, Afshin Samali
1Cell Stress and Apoptosis Research Group, Department of Biochemistry and the National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Ireland.
Brain Research
|December 4, 2003
Summary
Mild heat shock preconditioning protects against neurotoxin-induced cell death. Heat-shocked PC12 cells showed resistance to 1-methyl-4-phenylpyridinium (MPP(+)) neurotoxicity, suggesting a protective mechanism against Parkinson's disease models.
Area of Science:
- Neuroscience
- Cell Biology
- Toxicology
Background:
- Heat shock preconditioning induces thermotolerance and protection against cytotoxic agents.
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin used in Parkinson's disease models.
- MPTP selectively targets dopaminergic cells in the substantia nigra.
Purpose of the Study:
- To investigate the protective effects of heat shock preconditioning against MPP(+) neurotoxicity in PC12 cells.
- To determine if heat shock can prevent cell death induced by the Parkinson's disease-associated neurotoxin MPP(+).
Main Methods:
- PC12 cells were subjected to mild heat shock (1 h at 41.5°C).
- Heat shock-induced expression of heat shock proteins (Hsp25 and Hsp70) was monitored.
- Cells were treated with 1-methyl-4-phenylpyridinium (MPP(+)) to induce cell death.
- Cell death was assessed morphologically and by measuring caspase activity.
Main Results:
- Heat shock rapidly induced Hsp25 and Hsp70 levels, which remained elevated for at least 24 hours.
- MPP(+) treatment induced cell death, characterized as necrosis due to lack of caspase activity.
- Heat shocking PC12 cells 6 hours prior to MPP(+) exposure significantly inhibited MPP(+)-induced cell death.
Conclusions:
- Heat shock preconditioning confers significant protection against MPP(+) neurotoxicity in PC12 cells.
- This protective effect suggests a potential therapeutic strategy for conditions involving dopaminergic neurodegeneration, such as Parkinson's disease.